May 2024 Volume 20, Issue 3

DDN Magazine May 2024

Volume 20, Issue 3 | May 2024

May 2024

In this Issue

Aging

A close-up of a scientist’s hands in black gloves holding an obscured object under a microscope.

Reproductive aging leads to many women’s health problems

Slowing female reproductive aging could be the key to improving women’s health.
An illustrated image of an older woman looking at a younger version of herself with a clock behind them, representing reversing immune system aging

Explained: At what age does the immune system weaken?

After decades of combating daily assaults, the immune system undergoes dramatic changes that drastically affect human health.
Five cartoon vials of blood with a doctor holding a magnifying glass to one, symbolizing young blood rejuvenation therapy.

The science of young blood transfusions: can blood rejuvenate?

Explore the science behind young blood transfusion and blood rejuvenation therapy. Learn how researchers are studying the potential of young plasma to reverse the effects of aging.

RNA

A 3D rendering of a yellow lipid nanoparticle holding an mRNA therapeutic is shown entering a pink human cell.

Moderna’s path to mRNA therapies for rare metabolic disorders

Paolo Martini leads the biotech company’s rare disease research program with the hope of developing the very first treatments for genetic metabolic disorders.
A microscopic view of white, orange, and green molecules

Silencing genes to prevent disease with RNAi drugs

Alnylam Pharmaceuticals develops therapeutics based on the RNA interference (RNAi) pathway discovered in 1998.

Editor's Insight

Two profile outlines of humans with scientific and artistic images overlaid, symbolic of creativity in science.

Science needs creativity

The pursuit of scientific knowledge relies on analytical thinking, but creativity also plays an essential role.

Editor's Focus

White bowls with brown circular objects on a brown wooden background

A new Goldilocks drug class: macrocyclic peptides

By making peptides ring shaped, researchers uncovered a new class of drugs that is “just right” for previously undruggable targets.

Cell Therapy

Two Antion Biosciences researchers look at a fluorescent image on a computer monitor while wearing white lab coats and purple gloves.

Silencing cancer with CAR T cells

A new approach to cell engineering could make off-the-shelf CAR T cell therapies a reality.
Inside the robotic cluster at Multiply Labs

The robots making cell therapies

Scientists and engineers teamed up to use robots to streamline cell therapy manufacturing, aiming to give more patients access to these lifesaving therapies.

Protein Drugs

A scientist at Entact Bio works in the laboratory.

Targeting disease proteins with molecular matchmakers

Many diseases cause proteins to go haywire. Scientists are now developing drug molecules to change that.
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A network of interconnected human icons overlaid on a world map, representing global collaboration and population-scale data connections.
New collaborative initiatives are bringing pharmaceutical R&D together around large-scale datasets to accelerate therapeutic discovery.
Modeling neurotropic viral infections using human cerebral organoids
Using fetal-stage brain organoids, researchers are uncovering how Zika virus impacts neurodevelopment and contributes to microcephaly. 
Completing the real-time data picture in bioprocess development
Explore approaches to integrating timely protein titer measurements with cell health data to improve bioprocess visibility and decision-making.
Drug Discovery News December 2025 Issue
Latest IssueVolume 21 • Issue 4 • December 2025

December 2025

December 2025 Issue

Explore this issue